Effective use of cinacalcet for the treatment of secondary hyperparathyroidism in Austrian dialysis patients – Results of the Austrian cohort of the ECHO study

By Zitt Emanuel  

Wiener klinische Wochenschrift, Vol. 123, Iss. 1-2, 2011-01 ,pp. : 45-52

Springer Publishing Company

Access to resources Recommend Favorite

Cost per responder analysis in patients with secondary hyperparathyroidism on dialysis treated with cinacalcet

By Belozeroff Vasily   Lee Andrew   Tseng Spring   Chiroli Silvia   Campbell Jonathan D.  

Journal of Medical Economics, Vol. 16, Iss. 9, 2013-09 ,pp. : 1154-1162

Informa Healthcare

Access to resources Recommend Favorite

Paricalcitol Treatment of Secondary Hyperparathyroidism in Hemodialysis Patients: A German-Austrian, Single-Arm, Open-Label, Prospective, Noninterventional, Observational Study

By  

Nephron Clin Pract, Vol. 126, Iss. 1, 2014-01 ,pp. : 39-50

Karger

Access to resources Recommend Favorite

Influence on quality of life from an early cinacalcet prescription for secondary hyperparathyroidism in dialysis

By  

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, Vol. 24, Iss. 2, 2015-02 ,pp. : 187-196

John Wiley & Sons Inc

Access to resources Recommend Favorite

Reduction of whole PTH/intact PTH ratio as a predictor of bone metabolism in cinacalcet treatment of hemodialysis patients with secondary hyperparathyroidism

By Kurajoh M.   Inaba M.   Okuno S.   Nagayama H.   Yamada S.   Imanishi Y.   Ishimura E.   Shoji S.   Yamakawa T.   Nishizawa Y.  

Osteoporosis International, Vol. 22, Iss. 3, 2011-03 ,pp. : 923-930

Springer Publishing Company

Access to resources Recommend Favorite